Day 2225, 2.0 nmol/kg/day
Lausier J, Diaz WC, Roskens V, LaRock K, Herzer K, Fong CG, et al
To reiterate, hair loss is uncommon but not unheard of with GLP-1 medications: With Wegovy (semaglutide): About 3% of patients reported hair loss With Mounjaro (tirzepatide): About 5-6% of patients on the highest doses reported hair loss With Ozempic (lower-dose semaglutide): Participants didn't commonly report hair loss as a side effect This suggests that while the risk exists, most people taking Ozempic won't experience noticeable hair loss
Targeted delivery to peripheral nerves remains challenging due to the blood-nerve barrier, and off-target effects can pose safety risks
J.MorrowC
Nitric Oxide Production As mentioned earlier, glutathione is involved in the regulation of nitric oxide, a critical factor in blood vessel dilation